Influence of immobilization on bone mass and bone metabolism in hemiplegic elderly patients with a long-standing stroke

Significant bone mass reduction occurs in stroke patients on the hemiplegic side compared with the intact side, correlating with the degree of paralysis and vitamin D deficiency. To evaluate the influence of long-standing immobilization on this osteopenia, we measured various serum markers of bone metabolism in 93 hemiplegic elderly patients with a long-standing stroke and in 37 controls. The bone mineral density (BMD) of the second metacarpal was determined bilaterally. The scoring of the stroke patients activity was based on the Barthel Index (BI). The serum ionized calcium was higher in the patients than in the controls, correlating negatively with the BI in the patients. The concentrations of parathyroid hormone (PTH), pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen and bone Gla protein were normal or low. The serum 25-hydroxyvitamin D level was low in the patients, correlating positively with the BMD on both sides. The serum 1,25-dihydroxyvitamin D (1,25-[OH]2D) level was markedly reduced in the patients. Hemiplegia from a stroke can result in immobilization hypercalcemia which inhibits PTH secretion and 1,25-[OH]2D production. Bone remodelling may have almost reached an equilibrium, resulting in a steady rate of bone loss. This and the hypovitaminosis D appear to be the dominant causes of immobilization-induced osteopenia in elderly, long-standing hemiplegic stroke patients.

[1]  P. Virkkunen,et al.  Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. , 1992, British Journal of Cancer.

[2]  F. Biering-Sørensen,et al.  Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury , 1990, European journal of clinical investigation.

[3]  G E Dallal,et al.  Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. , 1997, The New England journal of medicine.

[4]  R. H. Meier,et al.  Bone metabolism in quadriplegia: dissociation between calciuria and hydroxyprolinuria. , 1975, Archives of physical medicine and rehabilitation.

[5]  R. Lindsay,et al.  Calcium Homeostasis of an Elderly Population upon Admission to a Nursing Home , 1993, Journal of the American Geriatrics Society.

[6]  E. Lowman,et al.  Mineral metabolism in spinal cord injury. , 1980, Archives of physical medicine and rehabilitation.

[7]  S. Brunnstrom,et al.  Motor testing procedures in hemiplegia: based on sequential recovery stages. , 1966, Physical therapy.

[8]  P. Dandona,et al.  Bone Density and Cortical Thickness in Nutritional Vitamin D Deficiency: Effect of Secondary Hyperparathyroidism , 1988, Annals of clinical biochemistry.

[9]  A. F. Stewart,et al.  Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. , 1982, The New England journal of medicine.

[10]  T. Steiniche,et al.  Changes in bone histomorphometry after long‐term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  K. Mann,et al.  Effect of renal function on plasma levels of bone Gla-protein. , 1983, The Journal of clinical endocrinology and metabolism.

[12]  A. Schoutens,et al.  Longitudinal study of calcium and bone metabolism in paraplegic patients , 1977, Paraplegia.

[13]  J. Lian,et al.  Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. , 1984, The Journal of clinical endocrinology and metabolism.

[14]  Robert A. Zimmerman,et al.  Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. , 1990, Stroke.

[15]  H. Maruoka,et al.  Development of osteopenia in the hemiplegic finger in patients with stroke. , 1996, European neurology.

[16]  L. Mosekilde,et al.  Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  M. Kleerekoper,et al.  Clinical Disorders of Bone and Mineral Metabolism , 1988 .

[18]  L. Avioli,et al.  Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass. , 1991, The Journal of clinical endocrinology and metabolism.

[19]  Mahoney Fi,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 1965 .

[20]  Yoshihiro Sato,et al.  High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease [RETRACTED] , 1997, Neurology.

[21]  H. Maruoka,et al.  Vitamin D deficiency and osteopenia in the hemiplegic limbs of stroke patients. , 1996, Stroke.

[22]  K. Mann,et al.  Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein. , 1983, The Journal of laboratory and clinical medicine.

[23]  J. Herbert,et al.  High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis , 1994, Neurology.

[24]  S. Mulaik,et al.  Single-sample tests for many correlations. , 1977 .

[25]  P. Schlesinger,et al.  Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. , 1990, The Journal of clinical investigation.

[26]  S. Ljunghall,et al.  Assessment of bone turnover with biochemical markers , 1989, Journal of internal medicine.